Gamida Cell Raises $75 Million Financing with Highbridge Capital Management
Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to developing and commercializing cures for blood cancers and serious hematologic diseases, today announced the sale of $75 million…
Continue Reading
Gamida Cell Raises $75 Million Financing with Highbridge Capital Management